[go: up one dir, main page]

Percy et al., 2023 - Google Patents

Current Status of Developmental Encephalopathies: Rett Syndrome, MECP2 Duplication Disorder, CDKL5 Deficiency Disorder and FOXG1 Disorder

Percy et al., 2023

View HTML
Document ID
15471385741736209740
Author
Percy A
Neul J
Peters S
Brockmann K
Marsh E
Benke T
Publication year
Publication venue
Translational Science of Rare Diseases

External Links

Snippet

This review describes the similarities and differences between the developmental encephalopathies including Rett syndrome (RTT), MECP2 Duplication Disorder (MDD), CDKL5 Deficiency Disorder (CDD), and FOXG1 Disorder (FD). RTT and MDD represent …
Continue reading at content.iospress.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • G06Q50/24—Patient record management
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00—Commerce, e.g. shopping or e-commerce
    • G06Q30/02—Marketing, e.g. market research and analysis, surveying, promotions, advertising, buyer profiling, customer management or rewards; Price estimation or determination
    • G06Q30/0207—Discounts or incentives, e.g. coupons, rebates, offers or upsales
    • G06Q30/0226—Frequent usage incentive systems, e.g. frequent flyer miles programs or point systems
    • G06Q30/0232—Frequent usage rewards other than merchandise, cash or travel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Similar Documents

Publication Publication Date Title
Pechmann et al. Evaluation of children with SMA type 1 under treatment with nusinersen within the expanded access program in Germany
Müller-Felber et al. Infants diagnosed with spinal muscular atrophy and 4 SMN2 copies through newborn screening–opportunity or burden?
List et al. Temporomandibular disorders: Old ideas and new concepts
McDermott et al. Diagnosis and management of motor neurone disease
Veauthier et al. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study
Lewis et al. Singing for lung health: service evaluation of the British lung foundation programme
Bangen et al. Cortical amyloid burden differences across empirically-derived mild cognitive impairment subtypes and interaction with APOE ɛ 4 genotype
Sürmeli et al. Obsessive compulsive disorder and the efficacy of qEEG-guided neurofeedback treatment: A case series
Graham et al. A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease
de Holanda Mendonça et al. Clinical outcomes in patients with spinal muscular atrophy type 1 treated with nusinersen
French et al. Efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal epilepsy: a phase 2b randomized clinical trial
Aldughmi et al. The relationship between fatigability and sleep quality in people with multiple sclerosis
Rugino Effect on primary sleep disorders when children with ADHD are administered guanfacine extended release
Michelini et al. The etiological structure of cognitive-neurophysiological impairments in ADHD in adolescence and young adulthood
Hjorth et al. Improving the physical health of long-term psychiatric inpatients
Siengsukon et al. Self-report sleep quality combined with sleep time variability distinguishes differences in fatigue, anxiety, and depression in individuals with multiple sclerosis: a secondary analysis
O’Mahony et al. Pediatric-onset multiple sclerosis is associated with reduced parental health–related quality of life and family functioning
McGrattan et al. Patients with spinal muscular atrophy type 1 achieve and maintain bulbar function following onasemnogene abeparvovec treatment
Niciu et al. The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder
Pfrimmer et al. Long-term outcome of infantile onset pompe disease patients treated with enzyme replacement therapy-data from a German-austrian cohort
Annexstad et al. Molecular and clinical characteristics of a national cohort of paediatric Duchenne muscular dystrophy patients in Norway
Fitzgerald et al. Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue
Lochmüller et al. Results from a 3-year non-interventional, observational disease monitoring program in adults with GNE myopathy
Zijlmans et al. Sleep, 24-hour activity rhythms, and cognitive reserve: a population-based study
Liu et al. Both subthalamic and pallidal deep brain stimulation are effective for GNAO1-associated dystonia: three case reports and a literature review